These results indicate the important role of StarD5 in maintaining the lipid homeostasis of the liver, which has implications for IR and dyslipidemia in the liver, such as MASLD and metabolic-associated steatohepatitis (MASH). This evidence concerns the gene STARD5 and metabolic dysfunction-associated steatotic liver disease.